Meds A-Z
Xylazine
Detailed information about Xylazine
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
To produce sedation, as an analgesic, and as a preanesthetic to local anesthesia. To produce sedation, accompanied by a shorter period of analgesia. May be used to calm and facilitate handling of fractious animals for di...
What it does:
To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia. To produce sedation, as an analgesic, and as a preanesthetic to local anesthesia. To produce sedation, accompanied by a shorter...
When it's needed:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 1...
Call your vet sooner if you notice:
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season.
Commonly reported reactions:
- (2 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Xylazine
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: MSK
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200088 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/140442 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 2 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 |
Species coverage: Dog (25) Cat (7)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case DEU-USFDACVM-2025-DE-000039
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 18 • Secondary summaries: 0
- A200088_Org_2_24_1994.pdf · FOI
- Sedazine™ · SPL
- UCM539440.pdf · FOI
- Xylazine HCl Injection · SPL
- AnaSed® Equine Injection · SPL
- ucm069889.pdf · FOI
- UCM508357.pdf · FOI
- UCM508360.pdf · FOI
- UCM474107.pdf · FOI
- Anased® · SPL
- Rompun® Injectable (100 mg) · SPL
- UCM396610.pdf · FOI
- XylaMed™ · SPL
- Rompun® Injectable (20 mg) · SPL
- A200139_Orig_05_16_1995.pdf · FOI
- Chanazine® · SPL
- A200184_Org_7_12_1996.pdf · FOI
- Chanazine® · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1343 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/329/Sedazine%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/484 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2513/Xylazine%20HCl%20Injection · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15564/AnaSed%C2%AE%20Equine%20Injection · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/455 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/453 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/454 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/452 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1431/Anased%C2%AE · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 11695-4024-1 | 11695 | - | |
| 17033-099-05 | 17033 | - | |
| 58597-8582-6 | 58597 | - | |
| 58597-8582-8 | 58597 | - | |
| 62157-373-01 | 62157 | - | |
| 62157-374-01 | 62157 | - | |
| 62991-1624-2 | 62991 | - | |
| 62991-1624-3 | 62991 | - | |
| 62991-1624-4 | 62991 | - | |
| 63537-0091-5 | 63537 | - | |
| 63537-0092-9 | 63537 | - | |
| 64189-9001-0 | 64189 | - | |
| 64189-9001-1 | 64189 | - | |
| 64189-9001-2 | 64189 | - | |
| 64189-9001-3 | 64189 | - | |
| 64189-9002-0 | 64189 | - | |
| 64189-9002-1 | 64189 | - | |
| 64189-9002-2 | 64189 | - | |
| 64189-9002-3 | 64189 | - | |
| 69043-043-05 | 69043 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
A200088_Org_2_24_1994.pdf
• FOI summary • Official
• May 12, 2025
FDA FOI summary for application 200088
-
UCM539440.pdf
• FOI summary • Official
• Feb. 26, 2025
FDA FOI summary for application 140442
-
UCM474107.pdf
• FOI summary • Official
• June 13, 2024
FDA FOI summary for application 139236
-
UCM508360.pdf
• FOI summary • Official
• June 13, 2024
FDA FOI summary for application 139236
-
UCM508357.pdf
• FOI summary • Official
• June 13, 2024
FDA FOI summary for application 139236
-
ucm069889.pdf
• FOI summary • Official
• June 13, 2024
FDA FOI summary for application 139236
-
UCM396610.pdf
• FOI summary • Official
• Feb. 27, 2023
FDA FOI summary for application 200529
-
A200139_Orig_05_16_1995.pdf
• FOI summary • Official
• July 28, 2017
FDA FOI summary for application 200139
-
A200184_Org_7_12_1996.pdf
• FOI summary • Official
• May 22, 2017
FDA FOI summary for application 200184
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domest… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Death, Lack of efficacy - NOS, Vomiting, Death by euthanasia, Hives (see also 'Skin'), INEFFECTIVE, ANESTHESIA. (Official, 2026-02-12)
- usage: To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia. To produce sedation, as an analgesic, and as a preanesthetic to lo… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Sedazine™
RX
Xylazine Hydrochloride
Liquid (Solution)
• Intramuscular, Intravenous
|
Boehringer lngelheim Animal Health USA Inc. | ANADA 200-088 | W | May 12, 2025 |
|
Xylazine HCl Injection AnaSed® Equine Injection
RX
Xylazine Hydrochloride
Injectable Solution
• Intramuscular, Intravenous
|
Cronus Pharma Specialities India Private Ltd. | NADA 140-442 | Approved | Feb 26, 2025 |
|
Anased®
RX
Xylazine Hydrochloride
Liquid (Solution)
• Subcutaneous, Intramuscular, Intravenous
|
Cronus Pharma Specialities India Private Ltd. | NADA 139-236 | Approved | Jun 13, 2024 |
|
Rompun® Injectable (100 mg)
RX
Xylazine Hydrochloride
Liquid (Solution)
• Intramuscular, Intravenous, Subcutaneous
|
Dechra, Ltd. | NADA 47956 | Approved | Nov 29, 2023 |
|
XylaMed™
RX
Xylazine
Injectable Solution
|
Bimeda Animal Health Limited | ANADA 200-529 | Approved | Feb 27, 2023 |
|
Rompun® Injectable (20 mg)
RX
Xylazine Hydrochloride
Liquid (Solution)
• Intravenous, Intramuscular, Subcutaneous
|
Dechra, Ltd. | NADA 47955 | Approved | Oct 28, 2021 |
|
Chanazine®
RX
Xylazine Hydrochloride
Liquid (Solution)
• Intravenous, Intramuscular
|
Chanelle Pharmaceuticals Manufacturing Ltd. | ANADA 200-139 | Approved | Jul 28, 2017 |
|
Chanazine®
RX
Xylazine Hydrochloride
Liquid (Solution)
• Subcutaneous, Intramuscular, Intravenous
|
Chanelle Pharmaceuticals Manufacturing Ltd. | ANADA 200-184 | Approved | May 22, 2017 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Do not use in horses intended for human consumption.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Do not use in horses intended for human consumption.
FDA page: Open in Animal Drugs @ FDA
Intramuscularly-1.0 mL/100 lbs body weight (1.0 mg/lb)
Following injection of XYLAMED, the animal should be allowed to rest quietly until the full effect has been reached.
These dosages produce sedation which is usually maintained for 1 to 2 hours, and analgesia which lasts for 15 to 30 minutes.
2. Preanesthetic to Local Anesthesia:
XYLAMED at the recommended dosages can be used in conjunction with local anesthetics, such as procaine or lidocaine.
3. Preanesthetic to General Anesthesia:
XYLAMED at the recommended dosage rates, produces an additive effect to central nervous system depressants such as pentobarbital sodium, thiopental sodium and thiamylal sodium. Therefore, the dosage of such compounds should be reduced and administered to the desired effect. In general, only 1/3 to ½ of the calculated dosage of the barbiturates will be needed to produce a surgical plane of anesthesia. Post-anesthetic or emergence excitement has not been observed in animals preanesthetized with XYLAMED.
XylaMed™ has been used successfully as a preanesthetic agent for pentobarbital sodium, thiopental sodium, thiamylal sodium, nitrous oxide, ether, halothane, glyceryl guaiacolate, and methoxyflurane anesthesia.
Horses: XYLAMED has been used successfully as follows:
1. Diagnostic procedures-oral and ophthalmic examinations, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations.
2. Orthopedic procedures, such as application of casting materials and splints.
3. Dental procedures.
4. Minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations.
5. To calm and facilitate handling of fractious animals.
6. Therapeutic medication for sedation and relief of pain following injury or surgery.
7. Major surgical procedures:
a. When used as a preanesthetic to general anesthesia.
b. When used in conjunction with local anesthetics.
Cervidae: XYLAMED may be used for the following:
1. To calm and facilitate handling of fractious animals.
2. Diagnostic procedures.
3. Minor surgical procedures.
4. Therapeutic medication for sedation and relief of pain following injury or surgery.
5. As a preanesthetic to local anesthesia.
XYLAMED at the recommended dosages can be used in conjunction with local anesthetics, such as procaine or lidocaine.
Dosage Range:
Fallow Deer (Dama dama)-2.0 to 4.0 mL/100 lbs body weight (2.0 to 4.0 mg/lb).
Mule Deer (Odocoileus hemionus)-1.0 to 2.0 mL/100 lbs body weight (1.0 to 2.0 mg/lb).
Sika Deer (Cervus nippon)-1.0 to 2.0 mL/100 lbs body weight (1.0 to 2.0 mg/lb).
White-Tailed Deer (Odocoileus virginianus)-1.0 to 2.0 mL/100 lbs body weight (1.0 to 2.0 mg/lb).
Elk (Cervus canadensis)-0.25 to 0.5 mL/100 lbs body weight (0.25 to 0.5 mg/lb).
Following injection of XYLAMED the animal should be allowed to rest quietly until the full effect has been reached.
These dosages produce sedation which is usually maintained for 1 to 2 hours and analgesia which lasts for 15 to 30 minutes
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
Sedazine (xylazine) should be used in horses and Cervidae when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia.
Horses: Sedazine has been used successfully as follows:
- Diagnostic procedures -- oral and opthalmic examinations, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations.
- Orthopedic procedures, such as application of casting materials and splints.
- Dental procedures.
- Minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations.
- To calm and facilitate handling of fractious animals.
- Therapeutic medication for sedation and relief of pain following injury or surgery.
- Major surgical proceduresÂ
- When used as a preanesthetic to general anesthesia.
- When used in conjunction with local anesthetics.
- Diagnostic procedures.
- Minor surgical procedures.
- Therapeutic medication for sedation and relief of pain following injury or surgery.
- As a preanesthetic to local anesthesia. Sedazine at the recommended dosages can be used in conjunction with local anesthetics, such as procain or lidocaine.
- Sedazine™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM539440.pdf
Summary
Xylazine HCl Injection should be used in horses when it is desirable to produce a state of sedation. It has been successfully used when conducting various diagnostic, orthopedic and dental procedures and for minor surgical procedures of short duration. It may also be used as a preanesthetic to local or general anesthesia.
- Xylazine HCl Injection (ZIP)
- AnaSed® Equine Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm069889.pdf
Summary
This supplement provides for a 300 mg/mL xylazine concentration, in addition to the approved concentration of 100 mg/mL for Cervidae. -
FOI UCM508357.pdf
Summary
This supplement provides for modification of the labeling to include use of AnaSed® 20 mg/mL in cats. -
FOI UCM508360.pdf
Summary
This supplement provides for modification of the labeling to include use of AnaSed; 100 mg/mL in Fallow Deer, Mule Deer, Sika Deer, White-tailed Deer, and Elk. -
FOI UCM474107.pdf
Summary
Supplement provides for use of the product in an additional species (dog).
- Anased® (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM396610.pdf
Summary
XYLAMED should be used in horses and Cervidae (Fallow Deer, Mule Deer, Sika Deer, White-Tailed Deer, and Elk) when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia.
Horses: XYLAMED has been used successfully as follows:
1. Diagnostic procedures-oral and ophthalmic examinations, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations.
2. Orthopedic procedures, such as application of casting materials and splints.
3. Dental procedures.
4. Minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations.
5. To calm and facilitate handling of fractious animals.
6. Therapeutic medication for sedation and relief of pain following injury or surgery.
7. Major surgical procedures:
a. When used as a preanesthetic to general anesthesia.
b. When used in conjunction with local anesthetics.
Cervidae: XYLAMED may be used for the following:
1. To calm and facilitate handling of fractious animals.
2. Diagnostic procedures.
3. Minor surgical procedures.
4. Therapeutic medication for sedation and relief of pain following injury or surgery.
5. As a preanesthetic to local anesthesia.
XYLAMED at the recommended dosages can be used in conjunction with local anesthetics, such as procaine or lidocaine..
- XylaMed™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
Summary
Chanazine (xylazine) should be used in horses and Cervidae when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia.
- Chanazine® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
Chanazine (xylazine) should be used in dogs and cats when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia. Xylazine has been used successfully as follows:
Diagnostic procedures - examination of mouth and ears, abdominal palpation, rectal palpation, vaginal examination, catheterization of the bladder and radiographic examinations.
Orthopedic procedures, such as application of casting materials and splints.
Dental procedures.
Minor surgical procedures of short duration such as debridement, removal of cutaneous neoplasms and suturing of lacerations.
To calm and facilitate restraint of fractious animals.
Therapeutic medication for sedation and relief of pain following injury or surgery.
Major surgical procedures:
When used as a preanesthetic to general anesthesia.
When used in conjunction with local anesthetics.
- Chanazine® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia. To produce sedation, as an analgesic, and as a preanesthetic to local anesthesia. To produce sedation, accompanied by a shorter period of analgesia. May be used to calm and facilitate handling of fractious animals for diagnostic procedures, for minor surgical procedures, for therapeutic medication for sedation and relief of pain following injury or surgery, and as a preanesthetic to local anesthetic. At the recommended dosages, can be used in conjunction with local anesthetics, such as procaine or lidocaine. To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 8 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Sheepdog - Old English (Bobtail), Male, 4 year, 37.8 kilogram • Drug: MSK, Unknown • Reactions: Malaise, Gastric ulcer, Peritonitis, Fluid in abdomen NOS, Fluid in abdomen NOS… • Outcome: Euthanized
- Report ID: DEU-USFDACVM-2025-DE-000039
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 4.00 Year
- Weight: 37.800 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, ['Domestic Shorthair', 'Domestic Shorthair', 'Domestic Shorthair', 'Domestic Shorthair'], Mixed, 2 year, 8.63 kilogram • Drug: MSK, Intramuscular, Dose: 5.50 Milligram per kilogram • Reactions: Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-049619
- Serious AE: Yes
- Treated For AE: No
- Sex: Mixed
- Age: 2.00 Year
- Weight: 8.630 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intramuscular
- Dose: 5.50 Milligram per kilogram
Cat, Domestic Shorthair, Male, 8 month • Drug: MSK, Unassigned, Intramuscular • Reactions: Death, Medication error NOS • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-021420
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Month
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intramuscular
- Form: Unassigned
Cat, Domestic Shorthair, Female, 5 year, 7.112 kilogram • Drug: MSK, Unassigned, Intramuscular • Reactions: Cyanosis, Death, Medication error NOS • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-019865
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 5.00 Year
- Weight: 7.112 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intramuscular
- Form: Unassigned
Cat, Domestic Shorthair, Male, 5 year • Drug: MSK, Unassigned, Intramuscular • Reactions: Death, Medication error NOS • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-019864
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 5.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intramuscular
- Form: Unassigned
Cat, Domestic Shorthair, Female, 8.5 year, 3.084 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Otitis NOS, Hind limb paralysis, Urinary retention, Abnormal radiograph finding, Intentional misuse • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-012093
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 8.50 Year
- Weight: 3.084 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Dog, 5 year, 7 kilogram • Drug: MSK, Injection, solution • Reactions: Excitation • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2024-US-070765
- Serious AE: No
- Treated For AE: No
- Age: 5.00 Year
- Weight: 7.000 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Form: Injection, solution
Dog, ['Coonhound (unspecified)', 'Dog (unknown)'], Male, 8.5 year, 29.483 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Reluctant to move, Limb weakness, Walking difficulty, Knuckling, Paraparesis… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2024-US-028777
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.50 Year
- Weight: 29.483 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.